Compara mètodes
Revisa els mètodes seleccionats l'un al costat de l'altre; les files que difereixen es ressalten.
| Modelatge Multillivell× | Emparellament per puntuació de propensió× | |
|---|---|---|
| Camp | Estadística per a la recerca | Estadística per a la recerca |
| Família | Process / pipeline | Process / pipeline |
| Any d'origen≠ | 1992 | 1983 |
| Autor original≠ | Anthony Bryk and Stephen Raudenbush | Paul Rosenbaum and Donald Rubin |
| Tipus | Method | Method |
| Font seminal≠ | Bryk, A. S., & Raudenbush, S. W. (1992). Hierarchical Linear Models: Applications and Data Analysis Methods. SAGE Publications. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Àlies≠ | HLM, mixed-effects models, random effects models, MLM | PSM, propensity score weighting, covariate balance |
| Relacionats | 3 | 3 |
| Resum≠ | Multilevel modeling (also called hierarchical linear modeling, mixed-effects modeling) is a statistical framework for analyzing data organized in nested or clustered structures—students within schools, patients within hospitals, repeated measures within individuals. Developed by Bryk and Raudenbush (1992), it accounts for dependency among observations and partitions variance into levels (within-cluster and between-cluster), enabling valid inference and revealing context effects. Essential in education, medicine, organizational research, and any field where data have natural hierarchies. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateConjunt de dades ↗ |
|
|